“With the new R&D focused company, we want to further strengthen our global market position and open up new application areas and target markets. Our team in Taipei will enable us to be even closer to our Asian partners and use local R&D and production resources,” says Dr. Jonas Schoendube, CEO of CYTENA in Germany.
CYTENA Bioprocess Solutions will focus on providing bioprocess solutions for pharmaceutical companies and leading research institutes. These solutions are based on an innovative microbioreactor called C.BIRD. The C.BIRD is the first microbioreactor to combine early stage cell culture screening, monitoring and optimization. This enables customers to save several weeks of cell line development by selecting the right clones or cell cultures very early in the process.
Jonas Schoendube is particularly pleased about the strong team on-site in Taiwan: “With Dr. Charles Tsai, CEO of CYTENA Bioprocess Solutions, and Elbert Chen, CFO of CYTENA Bioprocess Solutions, we have found partners who will use their expertise to drive the company forward. “
